Who are Neurent Medical's investors?

Neurent Medical's investors include Atlantic Bridge Ventures, Claret Capital Partners, Fountain Healthcare Partners, MVM Life Science Partners, Sofinnova Partners, Enterprise Ireland, EQT Life Sciences, Western Development Commission.

How much funding has Neurent Medical raised?

Neurent Medical has disclosed $135M raised across 2 rounds.

Neurent Medical

8 known investors

Find your way into Neurent Medical

Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurent Medical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.

Hardware Healthtech Medical Devices

Investors · 8

Atlantic Bridge Ventureslisted by Atlantic Bridge VenturesPalo Alto · $1M – $5M

How we know: Atlantic Bridge Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Claret Capital Partnerslisted by Claret Capital PartnersLondon

How we know: Claret Capital Partners's portfolio page · Not right? Tell us

Fountain Healthcare Partnerslisted by Fountain Healthcare PartnersDublin · $10.8M – $16.2M

How we know: Fountain Healthcare Partners's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

MVM Life Science Partnerslisted by MVM Life Science PartnersLondon · $20M – $100M

How we know: MVM Life Science Partners's portfolio page · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Enterprise IrelandreportedDublin · $800K

How we know: funding news · Not right? Tell us

EQT Life SciencesreportedAmsterdam · $11M – $66M

How we know: funding news · Not right? Tell us

Western Development CommissionreportedBallaghaderreen · $10.8K – $1.1M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$135M disclosed across 2 rounds · 2026

$67.5MraisedFeb 2026 · 2 sources
Source ↗
$67.5MSeries CFeb 2026 · 4 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Neurent raises $74M to commercialize treatment for nasal conditionfinance.yahoo.com · Feb 2026

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitisprnewswire.com · Feb 2026

Frequently asked questions

What does Neurent Medical do?: Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.
Who are Neurent Medical's investors?: Neurent Medical's investors include Atlantic Bridge Ventures, Claret Capital Partners, Fountain Healthcare Partners, MVM Life Science Partners, Sofinnova Partners, Enterprise Ireland, EQT Life Sciences, Western Development Commission.
How much funding has Neurent Medical raised?: Neurent Medical has disclosed $135M raised across 2 rounds.